Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel

Heather H Cheng, Roman Gulati, Arun Azad, Rosa Nadal, Przemyslaw Twardowski, Ulka N Vaishampayan, Neeraj Agarwal, Elisabeth Heath, Sumanta Pal, Hibba-tul Rehman, Amanda Leiter, Julia Batten, R Bruce Montgomery, Matthew D Galsky, Emmanuel S Antonarakis, Kim N Chi, Evan Yu

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Pages (from-to)122-127
Number of pages6
JournalProstate Cancer and Prostatic Diseases
Volume18
Issue number2
DOIs
Publication statusPublished - 2015
Externally publishedYes

Cite this

Cheng, Heather H ; Gulati, Roman ; Azad, Arun ; Nadal, Rosa ; Twardowski, Przemyslaw ; Vaishampayan, Ulka N ; Agarwal, Neeraj ; Heath, Elisabeth ; Pal, Sumanta ; Rehman, Hibba-tul ; Leiter, Amanda ; Batten, Julia ; Montgomery, R Bruce ; Galsky, Matthew D ; Antonarakis, Emmanuel S ; Chi, Kim N ; Yu, Evan. / Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel. In: Prostate Cancer and Prostatic Diseases. 2015 ; Vol. 18, No. 2. pp. 122-127.
@article{8e40b3e147154d82bcc7abc30a51a05a,
title = "Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel",
author = "Cheng, {Heather H} and Roman Gulati and Arun Azad and Rosa Nadal and Przemyslaw Twardowski and Vaishampayan, {Ulka N} and Neeraj Agarwal and Elisabeth Heath and Sumanta Pal and Hibba-tul Rehman and Amanda Leiter and Julia Batten and Montgomery, {R Bruce} and Galsky, {Matthew D} and Antonarakis, {Emmanuel S} and Chi, {Kim N} and Evan Yu",
year = "2015",
doi = "10.1038/pcan.2014.53",
language = "English",
volume = "18",
pages = "122--127",
journal = "Prostate Cancer and Prostatic Diseases",
issn = "1365-7852",
publisher = "Nature Publishing Group",
number = "2",

}

Cheng, HH, Gulati, R, Azad, A, Nadal, R, Twardowski, P, Vaishampayan, UN, Agarwal, N, Heath, E, Pal, S, Rehman, H, Leiter, A, Batten, J, Montgomery, RB, Galsky, MD, Antonarakis, ES, Chi, KN & Yu, E 2015, 'Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel' Prostate Cancer and Prostatic Diseases, vol. 18, no. 2, pp. 122-127. https://doi.org/10.1038/pcan.2014.53

Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel. / Cheng, Heather H; Gulati, Roman; Azad, Arun; Nadal, Rosa; Twardowski, Przemyslaw; Vaishampayan, Ulka N; Agarwal, Neeraj; Heath, Elisabeth; Pal, Sumanta; Rehman, Hibba-tul; Leiter, Amanda; Batten, Julia; Montgomery, R Bruce; Galsky, Matthew D; Antonarakis, Emmanuel S; Chi, Kim N; Yu, Evan.

In: Prostate Cancer and Prostatic Diseases, Vol. 18, No. 2, 2015, p. 122-127.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel

AU - Cheng, Heather H

AU - Gulati, Roman

AU - Azad, Arun

AU - Nadal, Rosa

AU - Twardowski, Przemyslaw

AU - Vaishampayan, Ulka N

AU - Agarwal, Neeraj

AU - Heath, Elisabeth

AU - Pal, Sumanta

AU - Rehman, Hibba-tul

AU - Leiter, Amanda

AU - Batten, Julia

AU - Montgomery, R Bruce

AU - Galsky, Matthew D

AU - Antonarakis, Emmanuel S

AU - Chi, Kim N

AU - Yu, Evan

PY - 2015

Y1 - 2015

U2 - 10.1038/pcan.2014.53

DO - 10.1038/pcan.2014.53

M3 - Article

VL - 18

SP - 122

EP - 127

JO - Prostate Cancer and Prostatic Diseases

JF - Prostate Cancer and Prostatic Diseases

SN - 1365-7852

IS - 2

ER -